宣痹通脉饮对冠心病患者FIB及hs-CRP水平的影响  

The Effect of Xuanbi Tongmai Drink on FIB and hs-CRP Levels of Patients with Coronary Heart Disease

作　　者：张丙义[1] 

机构地区：[1]河南省安阳职业技术学院医药卫生学院,河南安阳455000

出　　处：《中外医疗》2013年第33期16-16,18,共2页China & Foreign Medical Treatment

摘　　要：目的探讨宣痹通脉饮对冠心病患者血清超敏C反应蛋白(hs-CRP)及血浆凝血因子(FIB)水平的影响。方法选择冠心病(CHD)患者80例随机分为中西医结合治疗组40例及西药治疗组40例,检测各组治疗前后血液中FIB和hs-CRP水平。结果两组治疗前FIB和hs-CRP水平差异无统计意义(P>0.05);治疗后两组患者血清hs-CRP、FIB水平明显降低,差异有统计学意义(P<0.05);与对照组比较,治疗组患者治疗后FIB、hs-CRP水平显著降低,差异有统计学意义(P<0.05)。结论宣痹通脉饮可有效降低冠心病患者血清FIB、CRP水平。Objective To investigate the effect of Xuanbi Tongmai drink on the levels of serum high sensitivity C-reactive protein （hs-CRP） and plasma coagulation factor （FIB） of patients with coronary heart disease. Methods 80 patients with coronary heart dis- ease （CHD） were selected and randomly divided into integrated traditional Chinese and western medicine treatment group and western medicine treatment group with 40 cases in each. The levels of FIB and hs-CRP in the blood of patients of two groups were detected before and after the treatment. Results Before the treatment, the difference between the two groups in FIB and hs-CRP levels showed no statistical significance （/＇〉0.05）; after the treatment, serum hs-CRP and FIB levels of two groups were significant- ly lower, the difference was statistically significant （P〈0.05）; compared with the control group, the treatment group＇s FIB and hs- CRP levels after treatment were significantly lower, the difference was statistically significant （P〈0.05）. Conclusion Xuanbi Tong- maidrink can effectively reduce the levels of serum FIB and CRP of the patients with coronary heart disease.

关 键 词：冠心病 C反应蛋白 纤维蛋白原 宣痹通脉 

分 类 号：R541.4[医药卫生—心血管疾病]